ECHO ACCEPT -One EM Group's Approach to Opiate Use Disorder 1/19/2024 |
01/19/2024 - 12:15pm to 1:15pm CST |
ECHO ACCEPT - Pain Management at the End of Life for Patients with SUD 2/16/2024 |
02/16/2024 - 12:15pm to 1:15pm CST |
ECHO ACCEPT - Pain Management in the Setting of OUD + Buprenorphine Maintenance 3/15/2024 |
03/15/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT -A Brief Overview of 4th Edition ASAM Criteria to Connect Adults with Substance Use Disorders to the Best Level of Care 4/19/2024 |
04/19/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT - Overview of Xylazine – Appropriate Management 5/17/2024 |
05/17/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT - Research into Psychedelic Compounds as Treatment for SUDs 6/21/2024 |
06/21/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT - Stimulant Use Disorder – Review of ASAM Management Guidelines 7/19/2024 |
07/19/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT - Medications for Alcohol Use Disorder: Review of FDA approved and off-label MAUD 8/16/2024 |
08/16/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT - Plans for the Use of Wisconsin Opioid Settlement Funds 9/20/2024 |
09/20/2024 - 12:15pm to 1:15pm CDT |
ECHO ACCEPT - Top 10 Lessons Learned Using Long Acting Injectable Buprenorphine within the WI-DOC10/18/2024 |
10/18/2024 - 12:15pm to 1:15pm CDT |